Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Lyon
Clinical trial register · France

Clinical Trials in Lyon, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9722 matching records held by the registry are in this view. Synced 29 Oct 2026, 03:20 UTC
9722
Studies in scope
all four open statuses
6047
Recruiting now
open to new participants
1031
Lead sponsors
across recruiting studies
Top sites
Paris 2823 Lyon 1395 Bordeaux 1389 Marseille 1291 Lille 1281
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Hospices Civils de Lyon188 AstraZeneca60 Centre Leon Berard51 GCS Ramsay Santé pour l'Enseignement et la Recherche35 Hoffmann-La Roche35
Site location
Paris2823 Lyon1395 Bordeaux1389 Marseille1291 Lille1281
All 809 locations
Target enrolment
to

Trials with a site in Lyon

1395 of 9722 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Not yet open
GCS Ramsay Santé pour l'Enseignement et la Recherche
Not applicable
30
Lyon
2027-07
Not yet open
Risk-reducing Strategies, Including Fimbriectomy, in Women With a Germline Mutation Predisposing to Ovarian or Pelvic Cancer
NCT06726330Tubo-ovarian Carcinoma, High-grade Serous Carcinoma, Primary Peritoneal Carcinoma Stage III, Primary Peritoneal Carcinoma Stage IV
Centre Oscar Lambret
Not applicable
1,100
Lyon, Toulouse, Valenciennes, Bordeaux, Caen, Clermont-Ferrand, Dijon, Grenoble
2027-03
Not yet open
To Assess the Efficacy and Safety of Pegcetacoplan for the Prevention of Recurrent C3G or Primary IC-MPGN in Kidney Transplant Recipients
NCT07898774C3 Glomerulopathy (C3G), Primary Immune-Complex Membranoproliferative, Glomerulonephritis (IC-MPGN), Kidney Transplantation
DrugPegcetacoplan
Swedish Orphan Biovitrum
Phase 3
30
Strasbourg, Toulouse, Montpellier, Lille, Paris, Lyon
2027-01-21
Not yet open
Hospices Civils de Lyon
Observational
100
Angers, Caen, Clichy, Dijon, La Tronche, Lille, Lyon, Nantes
2027-01-01
Not yet open
Microbiota Changes Related to Outcomes in Kidney Transplantation
NCT07893691End-stage Renal Disease (ESRD), Kidney Transplantation
Hospices Civils de Lyon
Observational
30
Lyon
2027-01-01
Not yet open
University Hospital, Toulouse
Not applicable
266
Besançon, Créteil, Lyon, Marseille, Nantes, Paris, Rennes, Toulouse
2027-01-01
Not yet open
Institut Cancerologie de l'Ouest
Not applicable
144
Angers, Brest, La Roche-sur-Yon, Le Mans, Lille, Lyon, Saint-Nazaire
2027-01
Not yet open
Hospices Civils de Lyon
Phase 4
105
Bron, Lyon, Pierre-Bénite
2027-01
Not yet open
University Hospital, Lille
Observational
400
Béziers, Bordeaux, Brest, Caen, Lille, Lyon, Marseille, Nice
2027-01
Not yet open
What is the Role of the Exposome in Pulmonary Hypertension
NCT07172334Pulmonary Arterial Hypertension (PAH), Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Poitiers University Hospital
Observational
150
Bordeaux, Brest, Le Kremlin-Bicêtre, Lille, Lyon, Nancy, Poitiers, Saint-Etienne
2027-01
Not yet open
Assistance Publique Hopitaux De Marseille
Phase 4
224
Amiens, Avignon, Besançon, Bordeaux, Clermont-Ferrand, Lille, Lyon, Marseille
2027-01
Not yet open
The Lymphoma Academic Research Organisation
Phase 2
44
Angers, Caen, Chambéry, Clermont-Ferrand, La Roche-sur-Yon, Le Mans, Lille, Lyon
2026-12-31
Not yet open
Boehringer Ingelheim
Phase 3
270
Angers, Bordeaux, Caen, Lyon, Paris, Strasbourg, Toulouse
2026-12-14
Not yet open
Investigation of Type I Interferon Excess in Patients With Systemic Autoimmune Diseases and Genetic Type I Interferonopathies
NCT07837986Systememic Lupus Erythematosus, Systemic Sclerosis (SSc), Inflammatory Myopathies, Connective Tissue Diseases
DrugBiological samples
Hospices Civils de Lyon
Not applicable
120
Bron, Lyon, Oullins
2026-12-01
Not yet open
Centre Hospitalier Universitaire de Saint Etienne
Not applicable
160
Grenoble, Lyon, Saint-Etienne
2026-12-01
Not yet open
Optimizing Antibiotic Prescription in STI Clinics Using Rapid POCT
NCT07884656Chlamydia Trachomatis Infection, Neisseria Gonorrhoeae Infection, Sexually Transmitted Infections, Antimicrobial Resistance / Antibiotic Overuse
Hospices Civils de Lyon
Not applicable
404
Lyon
2026-12-01
Not yet open
Centre Hospitalier Universitaire de Saint Etienne
Phase 4
320
Avignon, Clermont-Ferrand, Grenoble, Le Puy-en-Velay, Lyon, Montpellier, Paris, Saint-Etienne
2026-12
Not yet open
Epcoritamab Plus Lenalidomide in Relapsed/Refractory Large B-cell Lymphoma After Second-Line CAR T-cell Therapy
NCT07814001Refractory Diffuse Large B-Cell Lymphoma (DLBCL), Refractory Large B-cell Lymphoma (LBCL), Refractory T-cell/Histiocyte-rich Large B-cell Lymphoma, Refractory Transformed Follicular Lymphoma
DrugsEpcoritamab·Lenalidomide
The Lymphoma Academic Research Organisation
Phase 2
55
Créteil, Dijon, Lille, Limoges, Lyon, Marseille, Montpellier, Nantes
2026-12
Not yet open
Hospices Civils de Lyon
Not applicable
59
Lyon
2026-12
Not yet open
The Lymphoma Academic Research Organisation
Phase 2
95
Lyon, Argenteuil, Avignon, Bayonne, Bordeaux, Cergy-Pontoise, Corbeil-Essonnes, Estaing
2026-12
Not yet open
PharmaMar
Phase 1/2
231
Bordeaux, Lyon, Nice
2026-11-12
Recruiting
Predicting Response to Anti-PD-1/PD-L1 Immunotherapy by Plasma Extracellular Vesicle Analysis
NCT07376512Non-Small Cell Lung Cancer, Melanoma (Skin Cancer)
Centre Georges Francois Leclerc
Observational
378
Besançon, Dijon, Lyon
2026-11-01
Not yet open
Two Modalities of Ventilation on the Occurrence of Respiratory Complications During Inhalational Anaesthetic Induction in Children
NCT07767851Anaesthetic Induction, Respiratory Complications of Care, Pediatrics, Ventilation
Hospices Civils de Lyon
Not applicable
2,032
Lyon, Marseille, Montpellier, Nantes, Paris, Reims, Strasbourg, Toulouse
2026-11-01
Not yet open
Hypercapnic Burden in Adults With Obesity Undergoing Diagnostic Polysomnography for Suspected Obstructive Sleep Apnea
NCT07809061Obstructive Sleep Apnea, Obesity (BMI>30), Obesity Hypoventilation Syndrome (OHS), Sleep Hypoventilation
Hospices Civils de Lyon
Not applicable
150
Lyon
2026-11-01
Not yet open
Assessment of the Preventive Effect of Defusing on Traumatic Kindling
NCT07850193Acute Stress Disorder, Post Traumatic Stress Disorder PTSD
Hospices Civils de Lyon
Not applicable
70
Chambéry, Lyon, Metz-Tessy, Paris
2026-11-01
Not yet open
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
158
Clermont-Ferrand, Lyon, Nice, Reims, Villejuif
2026-11
Not yet open
Biomarker Investigation for Early Gastric Cancer Detection
NCT07884669Gastro Oesophageal Cancer
Centre Leon Berard
Not applicable
100
Lyon
2026-11
Not yet open
Centre Leon Berard
Phase 1
26
Lyon
2026-11
Recruiting
TBF Genie Tissulaire
Phase 2
22
Lyon, Nantes, Saint-Jean-de-Védas
2026-11
Not yet open
FASTEN
Not applicable
144
Aix-en-Provence, Briis-sous-Forges, Lyon, Marseille, Montpellier, Neuilly-sur-Seine, Paris
2026-10-30
Not yet open
DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers
NCT07707895Small Cell Lung Cancer, Large Cell Neuroendocrine Lung Carcinoma, Extrapulmonary Neuroendocrine Carcinoma of Small Cell Histology, Extrapulmonary Neuroendocrine Carcinoma of Large Cell Histology
DrugsZL-1310·Obrixtamig·Atezolizumab
Boehringer Ingelheim
Phase 1/2
60
Lyon, Marseille, Villejuif
2026-10-28
Not yet open
Hospices Civils de Lyon
Not applicable
128
Bordeaux, Limoges, Lyon, Marseille, Paris, Tours
2026-10-22
Recruiting
Centre Médico-Chirurgical de Réadaptation des Massues Croix Rouge Française
Not applicable
15
Lyon
2026-10-19
Recruiting
Peer Support in Alcohol Dependence
NCT06381609Alcohol Use Disorder
Hospices Civils de Lyon
Not applicable
626
Bron, Clichy, Lyon, Paris
2026-10-19
Recruiting
Hospices Civils de Lyon
Observational
80
Lyon, Pierre-Bénite
2026-10-19
Not yet open
Medtronic MiniMed, Inc.
Not applicable
230
Caen, Grenoble, Lyon, Nîmes, Paris
2026-10-15
Not yet open
Takeda
Phase 2
36
Bordeaux, Créteil, Lyon, Toulouse
2026-10-15
Not yet open
GCS Ramsay Santé pour l'Enseignement et la Recherche
Not applicable
78
Lyon
2026-10-10
Not yet open
GCS Ramsay Santé pour l'Enseignement et la Recherche
Not applicable
50
Lyon
2026-10-01
Not yet open
Hospices Civils de Lyon
Observational
46
Lyon
2026-10-01
Not yet open
NutrImmune: Precision Nutrition to Improve Immunity in Individuals With Obesity
NCT07850206Obesity (BMI>30), Immune Abnormalities, Low-grade Inflammation
DrugBiological sampling
Institut National de la Santé Et de la Recherche Médicale, France
Not applicable
168
Lyon, Paris
2026-10-01
Not yet open
Nantes University Hospital
Not applicable
80
Ambon, Caen, Cugand, Éragny, Guidel, L'Île-Rousse, Lyon, Montpellier
2026-10-01
Not yet open
GCS Ramsay Santé pour l'Enseignement et la Recherche
Not applicable
121
Lyon
2026-10-01
Recruiting
ODSSEY-SCD_Identification Of Markers to preDict the rISk of Sudden Cardiac Death in Moderated LVEF in ischEmic cardiomyopathY
NCT07545512Myocardial Infarction (MI), Sudden Cardiac Death Due to Cardiac Arrhythmia
University Hospital, Clermont-Ferrand
Not applicable
400
Amiens, Brest, Caen, Clermont-Ferrand, Lille, Lyon, Nancy, Nantes
2026-10-01
Not yet open
University Hospital, Grenoble
Not applicable
987
Annecy, Bordeaux, Chambéry, La Roche-sur-Yon, Lyon, Nancy, Nantes, Rennes
2026-10-01
Not yet open
Hospices Civils de Lyon
Not applicable
42
Lyon
2026-10-01
Not yet open
GCS Ramsay Santé pour l'Enseignement et la Recherche
Not applicable
90
Lyon
2026-10-01
Recruiting
Boehringer Ingelheim
Phase 1/2
55
Lyon, Marseille, Villejuif
2026-10-01
Not yet open
Hospices Civils de Lyon
Phase 2
400
Bron, Créteil, Le Plessis-Robinson, Lyon, Marseille, Nantes, Paris, Pessac
2026-10
Not yet open
Early Optimization of Ceftazidime Regimen in Critical Care
NCT07085624Infection in ICU, Sepsis, Septic Shock, Pseudomonas Aeruginosa Infection
DrugCeftazidime
Centre Hospitalier Universitaire de Saint Etienne
Not applicable
128
Grenoble, Lyon, Marseille, Pierre-Bénite, Saint-Etienne
2026-10
Not yet open
Assembly Biosciences
Phase 2
80
Clichy, Créteil, Lyon
2026-10
Not yet open
GCS Ramsay Santé pour l'Enseignement et la Recherche
Not applicable
70
Lyon
2026-10
Not yet open
ARCAGY/ GINECO GROUP
Phase 2
63
Lyon, Paris
2026-10
Not yet open
University Hospital, Strasbourg, France
Phase 1/2
89
Bordeaux, Lille, Lyon, Marseille, Nancy, Paris, Strasbourg, Toulouse
2026-10
Not yet open
University Hospital, Bordeaux
Observational
1,200
Angers, Dijon, Limoges, Lyon, Nantes, Nîmes, Paris, Pessac
2026-10
Not yet open
Apmonia Therapeutics
Phase 1/2
48
Lyon, Villejuif
2026-10
Not yet open
GCS Ramsay Santé pour l'Enseignement et la Recherche
Not applicable
92
Lyon
2026-09-30
Recruiting
Corbus Pharmaceuticals Inc.
Phase 3
260
Saint-Herblain, Montpellier, Paris, Bordeaux, Dijon, Lyon, Marseille
2026-09-29
Recruiting
Evaluation of Diagnostic Accuracy and Clinical Performance of the UllCORE Bloodstream Infection (BSI) Test
NCT07859852Blood Stream Infection, Blood Stream Infections, Sepsis, Fungemia
Deepull Diagnostics S.L.
Observational
1,500
Limoges, Lyon
2026-09-21
Recruiting
Hospices Civils de Lyon
Not applicable
316
Amiens, Besançon, Bron, La Tronche, Lyon, Marseille, Nice, Saint-Priest-en-Jarez
2026-09-21
Not yet open
UNICANCER
Phase 2
51
Bordeaux, Lyon, Marseille, Nice, Paris, Rennes, Saint-Herblain, Toulouse
2026-09-18
Recruiting
Daiichi Sankyo
Phase 1/2
220
Caen, Dijon, Lille, Lyon, Marseille, Montpellier, Nice, Nîmes
2026-09-17
Not yet open
Assessment of Information Provided on Infectious Risk in Solid Organ Transplantation
NCT07788417Transplantation Infection, Pulmonary Transplantation
Fondation Hôpital Saint-Joseph
Observational
1,000
Paris, Bordeaux, Lyon, Marseille, Nantes, Strasbourg, Suresnes
2026-09-15
Not yet open
Validation Study of the ExéSem Battery Designed to Differentiate the Contribution of Executive Functions in Semantic Disorders
NCT07573046Alzheimer's Disease, Vascular Neurocognitive Disorder, Progressive Primary Aphasia Semantic Variant, People Without Neurocognitive Disorder
Hospices Civils de Lyon
Observational
140
Lyon
2026-09-09
Recruiting
Bristol-Myers Squibb
Phase 3
850
Marseille, Dijon, Nantes, La Tronche, Lyon, Paris, Bron, Villejuif
2026-09-08
Recruiting
University Hospital, Brest
Phase 3
418
Brest, Lyon
2026-09-04
Not yet open
Fondation Hôpital Saint-Joseph
Not applicable
2,400
Angers, Bobigny, Bordeaux, Clermont-Ferrand, Dijon, Le Plessis-Robinson, Lille, Lyon
2026-09-01
Not yet open
GCS Ramsay Santé pour l'Enseignement et la Recherche
Not applicable
50
Lyon
2026-09-01
Not yet open
Hospices Civils de Lyon
Phase 3
360
Amiens, Chalon-sur-Saône, Dieppe, Dijon, Garches, La Roche-sur-Yon, Le Mans, Lyon
2026-09-01
Not yet open
Hospices Civils de Lyon
Observational
300
Lyon, Pierre-Bénite
2026-09-01
Not yet open
Comparative Study of the Effectiveness of Three Access Routes for Implanting an Electronic Intracardiac Device
NCT07273929Primary Implantation of an Intracardiac Electronic Device Indication
Hospices Civils de Lyon
Phase 3
900
Clermont-Ferrand, Dijon, Lyon, Massy, Metz, Saint-Priest-en-Jarez
2026-09-01
Not yet open
University Hospital, Bordeaux
Phase 2
120
Bordeaux, Dijon, Lyon, Marseille, Montreuil, Nantes, Paris, Toulouse
2026-09
Recruiting
Nantes University Hospital
Not applicable
30
Lyon, Nantes, Paris
2026-09
Not yet open
GCS Ramsay Santé pour l'Enseignement et la Recherche
Not applicable
40
Lyon
2026-09
Not yet open
Hospices Civils de Lyon
Observational
108
Lyon
2026-09
Not yet open
GCS Ramsay Santé pour l'Enseignement et la Recherche
Phase 3
76
Lyon
2026-09
Not yet open
Carboplatin-Enhanced Therapy in BRCA-Mutated or Neuroendocrine-Differentiated Aggressive Metastatic Castration-Sensitive Prostate Cancer
NCT07591467BRCA-Mutated, Neuroendocrine-Differentiated Aggressive Metastatic Castration-Sensitive Prostate Cancer, Prostate Cancer
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
330
Bordeaux, Lyon, Marseille, Nancy, Villejuif
2026-09
Not yet open
GCS Ramsay Santé pour l'Enseignement et la Recherche
Not applicable
144
Lyon
2026-09
Not yet open
Centre Hospitalier Universitaire de Nīmes
Observational
300
Limoges, Lyon, Montpellier, Nîmes, Paris, Vandœuvre-lès-Nancy
2026-09
Not yet open
Centre Leon Berard
Phase 1/2
50
Bourg-en-Bresse, Clermont-Ferrand, Grenoble, Lille, Lyon, Marseille, Saint-Priest-en-Jarez, Toulouse
2026-09
Not yet open
UNICANCER
Phase 2
130
Auxerre, Beuvry, Caen, Calais, Compiègne, Coudekerque-Branche, Lille, Lyon
2026-08-31
Recruiting
Validation of the French Version of the New Mobility Score (NMS)
NCT07622095Hip Fractures, Mobility Limitation, Independence, Autonomy
Hospices Civils de Lyon
Observational
100
Lyon
2026-08-27
Recruiting
AstraZeneca
Phase 3
7,000
Corbeil-Essonnes, Grenoble, La Rochelle, Laval, Le Puy-en-Velay, Lyon, Metz-Tessy, Montpellier
2026-08-21
Recruiting
Gilead Sciences
Phase 2
120
Lyon, Marseille
2026-08-07
Recruiting
Eli Lilly and Company
Phase 2
606
Brest, Cholet, Créteil, La Tronche, Lyon, Marseille, Montpellier, Paris
2026-08-07
Recruiting
BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
NCT07625644Small Cell Lung Cancer Extensive Stage, Small-cell Lung Cancer, Small Cell Carcinoma, Sclc
DrugsEtoposide·Atezolizumab·Carboplatin
SystImmune Inc.
Phase 3
550
Créteil, Lyon, Marseille, Paris, Saint-Herblain
2026-08-04
Recruiting
Centre Hospitalier Universitaire de Saint Etienne
Not applicable
558
Caen, Grenoble, Lyon, Rouen, Saint-Etienne
2026-08-04
Not yet open
Verastem, Inc.
Phase 2
2
Lyon, Paris
2026-08-03
Not yet open
Intravenous Lidocaine for Hepatectomy
NCT07590830Hepatectomy
Rennes University Hospital
Phase 4
312
Clermont-Ferrand, La Roche-sur-Yon, Le Coudray, Lille, Lyon, Nice, Paris, Rennes
2026-08-01
Not yet open
Assistance Publique - Hôpitaux de Paris
Observational
200
Angers, Dieppe, Le Kremlin-Bicêtre, Lyon, Marseille, Rennes, Strasbourg
2026-08-01
Not yet open
ARCAGY/ GINECO GROUP
Phase 1/2
43
Bordeaux, Caen, Dijon, Lyon, Marseille, Montpellier, Pierre-Bénite, Rennes
2026-08
Not yet open
University Hospital, Grenoble
Observational
556
Clermont-Ferrand, Grenoble, Lyon, Marseille, Saint-Etienne
2026-08
Recruiting
VectivBio AG
Phase 3
124
Clichy, Lyon, Nantes, Pessac, Vandœuvre-lès-Nancy
2026-08
Not yet open
Centre Leon Berard
Not applicable
40
Lyon, Villefranche-sur-Saône
2026-07-30
Recruiting
GCS Ramsay Santé pour l'Enseignement et la Recherche
Not applicable
96
Lyon
2026-07-30
Recruiting
GlaxoSmithKline
Phase 3
800
Lyon, Reims
2026-07-27
Not yet open
Assistance Publique - Hôpitaux de Paris
Observational
25
Lille, Lyon, Paris
2026-07-15
Recruiting
Pulmonary Embolism in Patients With Acute Heart Failure (PEHF Study)
NCT07499661Acute Heart Failure (AHF), Pulmonary Embolism (Diagnosis), Venous Thromboembolism
University Hospital, Angers
Not applicable
740
Agen, Angers, Brest, Chambray-lès-Tours, Cholet, Clermont-Ferrand, La Tronche, Lyon
2026-07-15
Recruiting
Novartis Pharmaceuticals
Phase 3
710
Lyon
2026-07-10
Recruiting
Boehringer Ingelheim
Phase 3
390
Clichy, Dijon, Lyon, Marseille, Pessac, Rennes, Toulouse, Villejuif
2026-07-10
Recruiting
Fondation Ildys
Observational
343
Caen, Giens, Grenoble, Lille, Lyon, Montpellier, Paris, Reims
2026-07-09
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
134
Bordeaux, Nantes, Lyon
2026-07-06
Recruiting
Centre Hospitalier Universitaire de Saint Etienne
Not applicable
70
Angers, Clermont-Ferrand, Grenoble, Lille, Limoges, Lyon, Marseille, Nancy
2026-07-06
Not yet open
Multiple Myeloma t(4 ;14) FFPE Samples
NCT07482761Multiple Myeloma and Malignant Plasma Cell Neoplasms
BIWAKO
Observational
20
Lyon
2026-07-05
Recruiting
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
NCT07476287Small Cell Lung Cancer, Small Cell Lung Cancer ( SCLC ), Transformed Small Cell Lung Cancer, Lung Neoplasms
DrugPF-08634404
Pfizer
Phase 2
40
Lyon, Marseille, Villejuif
2026-07-02
Recruiting
Centre Médico-Chirurgical de Réadaptation des Massues Croix Rouge Française
Observational
70
Lyon
2026-07-01
Recruiting
Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance
NCT07636148Liver Cancer (Primary and Metastatic), Lung Cancer (Diagnosis), Bone Cancer Metastatic, Bone Cancer Tumor
Mark C Burgmans, MD PhD
Observational
2,000
Lyon, Créteil
2026-07-01
Not yet open
Hospices Civils de Lyon
Observational
279
Clermont-Ferrand, Lyon, Montpellier
2026-07-01
Not yet open
GCS Ramsay Santé pour l'Enseignement et la Recherche
Not applicable
60
Lyon
2026-07
Not yet open
GCS Ramsay Santé pour l'Enseignement et la Recherche
Not applicable
180
Lyon, Strasbourg
2026-07
Recruiting
Poitiers University Hospital
Not applicable
2,600
Angers, Grenoble, Le Coudray, Lille, Lyon, Marseille, Mont-de-Marsan, Nantes
2026-06-29
Recruiting
University Hospital, Montpellier
Phase 2
94
Bordeaux, Lyon, Montpellier, Paris, Poitiers, Toulouse
2026-06-25
Recruiting
A Study of ARC-02 in B-cell NHL
NCT07691606B-cell Non Hodgkin Lymphoma
DrugRituximab
Taiho Oncology, Inc.
Phase 1
140
Créteil, Lille, Lyon, Nantes, Villejuif
2026-06-22
Recruiting
GlaxoSmithKline
Phase 1/2
64
Bordeaux, Lyon, Villejuif
2026-06-22
Recruiting
Efficacy of 12-week Daytime Restricted Eating on Hepatic Steatosis of Obesity
NCT07378072MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)
Nantes University Hospital
Not applicable
72
Angers, Bordeaux, Dijon, Lyon, Marseille, Montpellier, Nantes, Paris
2026-06-17
Recruiting
Genotype/Phenotype Correlation of MORC2 Mutations
NCT07038239Charcot Marie Tooth Disease, DIFGAN, Developmental Delay (Disorder), Impaired Growth
Hospices Civils de Lyon
Observational
45
Besançon, Brest, Grenoble, Le Chesnay, Le Kremlin-Bicêtre, Lyon, Marseille, Nantes
2026-06-16
Not yet open
Liquid Biopsy in Early Colorectal Lesions
NCT07319104Colorectal Neoplasms, Precancerous Conditions, Adenocarcinoma of the Colon
University Hospital, Montpellier
Observational
1,000
Amiens, Bordeaux, Brest, Dijon, Limoges, Lyon, Montpellier, Nancy
2026-06-15
Recruiting
Boehringer Ingelheim
Phase 2
60
Lyon, Paris
2026-06-04
Recruiting
A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement
NCT07359820FGFR2 Gene Fusion/Rearrangement, Other Solid Tumors, Adult
Elevar Therapeutics
Phase 2
30
Bordeaux, Dijon, Lyon, Paris
2026-06-04
Recruiting
French Cardiology Society
Not applicable
250
Chambray-lès-Tours, Lyon, Pau, Pessac, Saint-Denis, Strasbourg, Toulouse
2026-06-02
Not yet open
A Brief Intervention by Nurses to Reduce the Prescribing of Occluded Peripheral Venous Catheters in the Emergency Department
NCT07584590an Initial Order for a Blood Draw and Placement of an IV Line in the Emergency Department
University Hospital, Rouen
Not applicable
1,680
Amiens, Angers, Clermont-Ferrand, Créteil, Dieppe, Eaubonne, Lyon, Marseille
2026-06-01
Not yet open
FEcal tranSplantation in HidradeniTIs suppuratiVA : a piLot Study
NCT07668713Hidradenitis Suppurativa (HS), Fecal Microbiota Transplantation (FMT)
DrugFecal Microbiota Transplantation
University Hospital, Clermont-Ferrand
Phase 1
24
Bordeaux, Clermont-Ferrand, Lyon, Marseille, Montpellier, Rodez
2026-06-01
Not yet open
University Hospital, Toulouse
Not applicable
216
Angers, Clichy, Dijon, Lyon, Nantes, Paris, Pessac, Toulouse
2026-06-01
Not yet open
The MAI-FOIE Cohort
NCT07594990Autoimmune Liver Diseases, Immunological Mechanisms
Nantes University Hospital
Observational
800
Angers, Brest, Clichy, La Roche-sur-Yon, Lille, Lyon, Nantes, Paris
2026-06-01
Not yet open
Gustave Roussy, Cancer Campus, Grand Paris
Observational
1,100
Caen, Clermont-Ferrand, Clichy, Dijon, Lille, Lyon, Marseille, Paris
2026-06
Not yet open
Heterogeneity of Oral Carcinogenesis: From PrEneoplasia to Invasive Squamous Cell Carcinoma
NCT07579507Oral Squamous Cell Carcinomas, Oral Potentially Malignant Disorder
Centre Leon Berard
Not applicable
150
Lyon
2026-06
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Amiens, Lyon, Montpellier, Nantes, Poitiers, Talence, Toulouse, Tours
2026-05-31
Recruiting
BeOne Medicines
Phase 3
1,056
Bordeaux, Lyon, Marseille, Montpellier, Rennes, SaintHerblain, Villejuif
2026-05-22
Recruiting
Hoffmann-La Roche
Phase 2/3
650
Grenoble, Lyon, Nice, Rennes, Toulouse
2026-05-21
Recruiting
Hospices Civils de Lyon
Not applicable
182
Lyon, Saint-Priest-en-Jarez
2026-05-21
Recruiting
GCS Ramsay Santé pour l'Enseignement et la Recherche
Not applicable
60
Lyon
2026-05-15
Recruiting
Ipsen
Phase 3
350
Lille, Lyon, Montpellier, Nantes, Paris, Toulouse, Villejuif
2026-05-14
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
20,000
Lyon, Paris
2026-05-11
Recruiting
PET-MRI of Reward System in Parkinson's Disease With RBD
NCT07213219Parkinson's Disease (PD)
University Hospital, Clermont-Ferrand
Not applicable
44
Clermont-Ferrand, Le Puy-en-Velay, Lyon
2026-05-07
Recruiting
EMD Serono Research & Development Institute, Inc.
Phase 3
1,020
Bordeaux, Lille, Saint Priest En Jarez, Lyon, Villejuif, Paris
2026-05-06
Recruiting
AstraZeneca
Phase 3
59
Aix-en-Provence, Brest, Colmar, Gleizé, Grenoble, Lyon, Marseille, Montpellier
2026-05-05
Not yet open
Hospices Civils de Lyon
Observational
96
Lyon
2026-05-04
Not yet open
Screening for MASLD-related Advanced Fibrosis in Type 2 Diabetes
NCT07270822Steatotic Liver Disease, Fibrosis of Liver
Hospices Civils de Lyon
Not applicable
1,714
Caluire-et-Cuire, Lyon, Saint-Maurice-l'Exil, Sathonay-Camp
2026-05-01
Not yet open
Hospices Civils de Lyon
Not applicable
100
Lyon
2026-05-01
Not yet open
Centre Leon Berard
Not applicable
300
Lyon
2026-05-01
Not yet open
Molnlycke Health Care AB
Not applicable
386
Castelnau-le-Lez, Grenoble, Lyon, Nantes, Poitiers, Toulouse
2026-05
Not yet open
Hôpital le Vinatier
Not applicable
90
Bron, Lyon
2026-05
Recruiting
Assistance Publique Hopitaux De Marseille
Observational
675
Bordeaux, Lyon, Marseille, Nantes, Paris, Toulouse
2026-04-29
Recruiting
GCS Ramsay Santé pour l'Enseignement et la Recherche
Not applicable
200
Lyon
2026-04-29
Recruiting
Alkermes, Inc.
Phase 3
176
Bordeaux, Lyon, Montpellier
2026-04-22
Recruiting
Centre Médico-Chirurgical de Réadaptation des Massues Croix Rouge Française
Not applicable
70
Lyon
2026-04-21
Recruiting
PSYLIVER-PILOTE: Involvement of the Autonomic Nervous System in Hepatocellular Carcinoma (HCC)
NCT07393074Hepato Cellular Carcinoma, Cirrhosis, Autonomic Nervous System, Central Nervous System
Hospices Civils de Lyon
Not applicable
100
Lyon
2026-04-17
Recruiting
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Phase 3
420
Besançon, Brest, Dijon, Lyon, Paris, Pierre-Bénite, Saint-Herblain, Strasbourg
2026-04-17
Recruiting
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
150
Clémont, Lyon, Paris
2026-04-16
Recruiting
Visugromab in Cachexia International Trial
NCT07112196Cancer-associated Cachexia
DrugVisugromab
CatalYm GmbH
Phase 2/3
518
Brest, Créteil, Lyon, Strasbourg
2026-04-16
Recruiting
ETOP IBCSG Partners Foundation
Phase 2
48
Angers, Bordeaux, Lyon, Marseille
2026-04-15
Recruiting
AstraZeneca
Phase 3
245
Clermont-Ferrand, Lyon, Marseille, Paris, Pessac, Saint-Denis, Saint-Pierre, Toulon
2026-04-13
Recruiting
Incyte Corporation
Phase 3
588
Brest, Dijon, Lille, Lyon, Marseille, Montpellier, Paris, Pessac
2026-04-09
Recruiting
University Hospital, Toulouse
Observational
120
Bordeaux, Caen, Lille, Lyon, Marseille, Paris, Rennes
2026-04-07
Recruiting
Hoffmann-La Roche
Phase 2
80
Lille, Lyon, Marseille, Montpellier, Toulouse
2026-04-07
Recruiting
Alkermes, Inc.
Phase 3
150
Bordeaux, Lyon, Montpellier
2026-04-06
Not yet open
Centre Leon Berard
Not applicable
10
Lyon
2026-04-05
Not yet open
Assistance Publique - Hôpitaux de Paris
Observational
350
Bordeaux, Clamart, Clermont-Ferrand, Le Kremlin-Bicêtre, Lille, Lyon, Martigues, Nancy
2026-04-01
Not yet open
University Hospital, Tours
Observational
60
Limoges, Lyon, Tours
2026-04
Not yet open
University Hospital, Grenoble
Not applicable
540
Angers, Clermont-Ferrand, Clichy, Grenoble, Le Kremlin-Bicêtre, Lille, Lyon, Marseille
2026-04
Recruiting
Otto Bock France SNC
Not applicable
77
Berck, Créteil, Dijon, Gaillac-Toulza, Garches, Lomme, Lyon, Nice
2026-03-30
Not yet open
Hospices Civils de Lyon
Not applicable
45
Lyon
2026-03-30
Recruiting
AstraZeneca
Phase 2
43
Bordeaux, Créteil, Lyon, Nantes, Nîmes
2026-03-28
Recruiting
Anesthesia Management in Endovascular Therapy for Ischemic Stroke - 2
NCT07235514Ischemic Stroke, Anterior Cerebral Circulation, General Anesthesia, Procedural Sedation
University Hospital, Clermont-Ferrand
Not applicable
958
Angers, Brest, Clermont-Ferrand, Lille, Lyon, Marseille, Montpellier, Nantes
2026-03-24
Recruiting
University Hospital, Tours
Observational
149
Angers, Bordeaux, Brest, Dijon, Grenoble, Lille, Lyon, Marseille
2026-03-23
Recruiting
Hoffmann-La Roche
Phase 3
1,600
Lyon, Marseille, Nice, Paris, Tours
2026-03-23
Recruiting
Centre Hospitalier Universitaire de Saint Etienne
Not applicable
196
Lyon, Marseille, Saint-Etienne
2026-03-19
Recruiting
Centre Hospitalier de PAU
Observational
1,000
Annecy, Bordeaux, Chalon-sur-Saône, Lyon, Paris, Strasbourg, Toulouse, Tours
2026-03-19
Recruiting
Nantes University Hospital
Not applicable
1,401
Nantes, Brest, Lyon, Montpellier, Paris, Saint-Etienne
2026-03-18
Recruiting
Immunoparalysis After Pancreaticoduodenectomy
NCT07144917Pancreatic Ductal Adenocarcinoma (mPDAC), Pancreatic Head Tumour, Pancreatic Fistula
Hospices Civils de Lyon
Observational
100
Lyon, Pierre-Bénite
2026-03-18
Recruiting
Nantes University Hospital
Not applicable
560
Lyon, Nantes, Nîmes, Paris, Poitiers, Saint-Herblain, Villejuif
2026-03-13
Recruiting
Centre Hospitalier Universitaire de Nice
Phase 2
56
Nice, Paris, Bordeaux, La Réunion, Lyon
2026-03-12
Recruiting
Hoffmann-La Roche
Phase 2
100
Bordeaux, Villejuif, Lyon, Marseille
2026-03-11
Recruiting
Homelessness and Prevalence of Neurodevelopmental Disorders
NCT06869915Neurodevelopmental Disorders
Hôpital le Vinatier
Not applicable
150
Lyon
2026-03-09
Recruiting
Novartis Pharmaceuticals
Phase 2
272
Lyon, Créteil, Dijon, Paris
2026-03-09
Recruiting
Hospices Civils de Lyon
Not applicable
210
Belley, Beynost, Bron, Craponne, Crêches-sur-Saône, Gleizé, LArbresle, Lyon
2026-03-06
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Caen, La Tronche, Le Mans, Lyon, Paris, Toulouse
2026-03-05
Recruiting
Efficacy and Safety of the Valemetostat in Patients With Selected Solid Tumors.
NCT07303387Solid Tumor Malignancies, Clear Cell Endometrial Carcinoma, Ovarian Cancer
DrugValemetostat Tosylate
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2
900
Villejuif, Bordeaux, Lyon, Paris
2026-03-05
Recruiting
Tandem Diabetes Care, Inc.
Observational
350
Agen, Angers, Bron, Dijon, Lyon, Mainvilliers, Marseille, Meaux
2026-03-03
Recruiting
Uppsala University
Observational
2,000
Lyon
2026-03-01
Recruiting
Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Advanced Pancreatic Cancer
NCT06755359Pancreatic Cancer, Locally Advanced Pancreatic Cancer
Alpha Tau Medical LTD.
Not applicable
40
Bordeaux, Clermont-Ferrand, Dijon, Grenoble, Lyon, Marseille, Poitiers, Villejuif
2026-03-01
Not yet open
IHU Strasbourg
Observational
300
Aix-en-Provence, Besançon, Échirolles, Lille, Lyon, Montpellier, Saint-Etienne, Sète
2026-03
Not yet open
Food-related Quality of Life in Patients With Cancer
NCT07437326Breast Cancer, Head and Neck Cancers, Gynecologic Cancer, Gastrointestinal Cancer
Hospices Civils de Lyon
Observational
180
Bron, Lyon, Oullins
2026-03
Not yet open
Centre Leon Berard
Not applicable
100
Lyon
2026-03
Recruiting
Mirum Pharmaceuticals, Inc.
Phase 2/3
120
Bordeaux, Clermont-Ferrand, Clichy, Créteil, Grenoble, Lille, Limoges, Lyon
2026-02-26
Recruiting
Circadian Rhythm Deregulation in Patients With CAPS
NCT06544018Cryopyrin Associated Periodic Syndrome, Familial Cold Urticaria, Muckle-Wells Syndrome, CINCA Syndrome
DrugBlood sampling
Hospices Civils de Lyon
Not applicable
30
Bron, Lille, Lyon, Paris
2026-02-25
Recruiting
GCS Ramsay Santé pour l'Enseignement et la Recherche
Not applicable
150
Lyon
2026-02-24
Recruiting
Quality of Life After Glaucoma Surgery: Evaluating the Patient Perspective Across Surgical Options
NCT07303257Glaucoma Eye, Open-angle Glaucoma, Closed-Angle Glaucoma, Pseudo Exfoliative Syndrome
Hospices Civils de Lyon
Observational
132
Lyon
2026-02-23
Recruiting
UNICANCER
Not applicable
1,508
Lyon, Villejuif
2026-02-19
Active, closed
Ipsen
Phase 3
1,300
Lyon, Nice, Paris
2026-02-18
Recruiting
Boehringer Ingelheim
Phase 3
286
Amiens, Bordeaux, Brest, Créteil, Lyon, Nice, Nîmes, Paris
2026-02-16
Recruiting
ShockFast Intravascular Lithotripsy Device for Treatment of Calcified Coronary Lesions
NCT07407738Coronary Arterial Disease, Calcified Coronary Artery Disease
Shunmei Medical
Not applicable
120
Lyon, Paris, Valenciennes
2026-02-16
Recruiting
Merck Sharp & Dohme LLC
Phase 3
900
Lyon, Strasbourg, Marseille, Plérin, Brest, Toulouse, Limoges, Tours
2026-02-16
Recruiting
Pfizer
Phase 2/3
1,156
Montpellier, Paris, Epagny Metz-Tessy, Lyon
2026-02-11
Recruiting
Nantes University Hospital
Phase 3
222
Aix-en-Provence, Angers, Brest, Lille, Lyon, Nantes, Rennes
2026-02-09
Recruiting
Janssen Research & Development, LLC
Phase 3
400
Lille, Lyon, Nancy, Nantes, Paris, Pessac, Poitiers, Toulouse
2026-02-04
Recruiting
AstraZeneca
Phase 3
2,130
Bordeaux, Caen, Lyon, Marseille, Rennes, Villejuif
2026-02-03
Recruiting
Childhood Toxin Perception Survey
NCT07377201Cerebral Palsy (CP)
Centre Médico-Chirurgical de Réadaptation des Massues Croix Rouge Française
Observational
500
Lyon
2026-02-01
Recruiting
Rabin Medical Center
Phase 3
254
Angers, Le Kremlin-Bicêtre, Lyon, Marseille, Paris
2026-02-01
Not yet open
MAIT Cells in Hidradenitis Suppurativa
NCT07388446Hidradenitis Suppurativa (HS)
Hospices Civils de Lyon
Not applicable
45
Lyon
2026-02-01
Not yet open
Centre Leon Berard
Observational
30
Lyon
2026-02
Recruiting
Lifestyle Intervention Among Participants of the French Colorectal Cancer Screening Program (LIFE-SCREEN)
NCT06827366Colorectal Cancer Screening, Colorectal Cancer Prevention, Colorectal Cancer
Centre Leon Berard
Not applicable
800
Lyon
2026-01-26
Recruiting
Takeda
Phase 2
90
Nice, Marseille, Martigues, Lyon, Le Mans, Rouen
2026-01-26
Recruiting
BeOne Medicines
Phase 3
500
Bordeaux, ClermontFerrand, Le Mans, Lille, Lyon, Montpellier, Toulouse
2026-01-22
Recruiting
Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma
NCT06254248Liver Transplant, Hepatocellular Carcinoma Recurrent, Systemic Treatment
Assistance Publique - Hôpitaux de Paris
Phase 2
50
Clichy, Créteil, Lille, Lyon, Montpellier, Paris, Rennes, Strasbourg
2026-01-22
Recruiting
Centre Leon Berard
Not applicable
100
Bourgoin, Grenoble, Lyon, Saint-Etienne, Villefranche-sur-Saône
2026-01-21
Recruiting
Vorasidenib Maintenance for IDH Mutant Astrocytoma
NCT06809322IDH-mutant Grade 2 or 3 Astrocytoma
DrugVorasidenib
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
468
Bordeaux, Lyon, Marseille, Paris, Toulouse
2026-01-16
Recruiting
Hospices Civils de Lyon
Phase 2/3
93
Bron, Lyon
2026-01-15
Recruiting
Neo-adjuvant Immunotherapy in Patients With Localized Melanoma
NCT07230613Cutaneous Melanoma, Stage III, Mucosal Melanoma
DrugsIpilimumab·Nivolumab
UNICANCER
Phase 2
50
Bordeaux, Lyon, Marseille, Paris, Villejuif
2026-01-12
Recruiting
Impact of Bevel Orientation on Arteriovenous Fistula Puncture in Hemodialysis
NCT06708338End-Stage Renal Disease Requiring Haemodialysis
Centre Hospitalier Emile Roux
Not applicable
240
Le Puy-en-Velay, Lyon, Moulins, Poissy
2026-01-07
Recruiting
Biogen
Phase 2
81
Bordeaux, La Tronche, Lyon, Toulouse
2026-01-05
Recruiting
Hospices Civils de Lyon
Observational
114,230
Lyon
2026-01-05
Recruiting
Institut Curie
Not applicable
450
Avignon, Bordeaux, Clermont-Ferrand, Lyon, Marseille, Montpellier, Nîmes, Paris
2026-01-05
Recruiting
Hospices Civils de Lyon
Observational
200
Lyon
2026-01-04
Not yet open
Hospices Civils de Lyon
Not applicable
1,665
Lyon
2026-01-02
Recruiting
Amgen
Phase 2
14
Lyon
2026-01-02
Not yet open
Volatile Organic Compounds Analysis by GC-MS for Diagnostic of Hospitalised Patients With Respiratory Infections Using Exhaled Breath
NCT07352462Respiratory Infections, COVID-19, Influenza Virus Infection, Legionella Pneumophila Infections
Hospices Civils de Lyon
Not applicable
777
Lyon
2026-01-01
Not yet open
Hospices Civils de Lyon
Not applicable
54
Lyon
2026-01
Not yet open
University Hospital, Bordeaux
Observational
450
Amiens, Bois-Guillaume, Bordeaux, Caen, Créteil, Grenoble, Lille, Lyon
2026-01
Recruiting
AEF0217 in Participants With Down Syndrome
NCT07334912Down Syndrome (Trisomy 21)
Aelis Farma
Phase 2
188
Bordeaux, Lyon, Montpellier, Paris, Saint-Etienne
2025-12-22
Recruiting
Centre Médico-Chirurgical de Réadaptation des Massues Croix Rouge Française
Not applicable
40
Lyon
2025-12-22
Recruiting
Eli Lilly and Company
Phase 3
800
Avignon, Besançon, Brest, Clermont-Ferrand, Dijon, Le Mans, Lyon, Montpellier
2025-12-22
Recruiting
Taiho Oncology, Inc.
Phase 3
360
Bordeaux, Bron, Lyon, Pierre-Bénite, Villefranche-de-Rouergue, Caen, Nîmes, Mulhouse
2025-12-22
Recruiting
Centre Hospitalier Universitaire de Besancon
Phase 2
75
Besançon, Dijon, Grenoble, Lyon, Montpellier, Paris, Rennes, Tours
2025-12-22
Recruiting
nChroma Bio
Phase 1/2
66
Lyon
2025-12-22
Recruiting
Janssen Research & Development, LLC
Phase 3
800
Bordeaux, Clermont-Ferrand, Lille, Lyon, Nîmes, Paris, Rennes, Villejuif
2025-12-19
Recruiting
Post-market Clinical Follow-up Study of NEMOST V2
NCT07403084Scoliosis Neuromuscular, Scoliosis Idiopathic, Consent Forms
EUROS
Not applicable
140
Nice, Bordeaux, Lyon, Paris
2025-12-19
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
570
Bordeaux, Toulouse, Nantes, Lyon, Bobigny, Paris
2025-12-18
Recruiting
ArriVent BioPharma, Inc.
Phase 3
480
Bron, Marseille, Caen, Toulouse, Lyon, Saint-Herblain
2025-12-17
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
41
Lyon, Paris, Rennes, Toulouse
2025-12-16
Not yet open
University Hospital, Clermont-Ferrand
Not applicable
120
Clermont-Ferrand, Lyon
2025-12-15
Not yet open
Normothermic Oxygenated Perfusion (NMP) Viability Testing Before Transplantation of Discarded Livers
NCT06950398Organ Transplantation, Liver Dysfunction, Liver Diseases
Rennes University Hospital
Phase 2
99
Clichy, Lyon, Montpellier, Rennes, Tours, Villejuif
2025-12-15
Recruiting
Angitia Incorporated Limited
Phase 2
80
Lyon, Paris
2025-12-12
Recruiting
Centre Hospitalier Universitaire de Saint Etienne
Observational
80
Bron, Clermont-Ferrand, Grenoble, Lyon, Saint-Etienne
2025-12-11
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
1,000
Angers, Bordeaux, Brest, Lille, Lyon, Marseille, Paris, Strasbourg
2025-12-11
Recruiting
AstraZeneca
Phase 2
230
Lyon, Montpellier, Nantes, Nîmes, Paris, Tours
2025-12-10
Recruiting
Incyte Corporation
Phase 3
466
Avignon, Bordeaux, Chambray-lès-Tours, La Roche-sur-Yon, La Tronche, Lyon, Marseille, Nice
2025-12-09
Recruiting
Autonomous Methadone Delivery System by Nurses
NCT07085377Opioid Use Disorder (OUD), Addictology
Hospices Civils de Lyon
Not applicable
182
Bayonne, Bordeaux, Brioude, Le Puy-en-Velay, Lyon, Strasbourg, Villeurbanne
2025-12-08
Recruiting
Cystinosis and Mitochondrial Metabolism
NCT07319091Cystinosis, Native Kidney
Hospices Civils de Lyon
Not applicable
25
Bron, Lille, Lyon, Marseille, Montpellier, Paris, Vandœuvre-lès-Nancy
2025-12-08
Recruiting
Centre Leon Berard
Phase 3
132
Brest, Clermont-Ferrand, Lyon, Marseille, Paris, Poitiers
2025-12-08
Recruiting
Ipsen
Phase 1/2
114
Lyon, Saint-Herblain, Villejuif
2025-12-05
Recruiting
GlaxoSmithKline
Phase 3
450
Angers, Bordeaux, Lille, Lyon, Marseille, Saint-Herblain, Toulouse, Villejuif
2025-12-03
Recruiting
Daiichi Sankyo
Phase 1
60
Lille, Lyon
2025-12-03
Not yet open
Hospices Civils de Lyon
Observational
100
Lyon
2025-12-01
Active, closed
Institut Cancerologie de l'Ouest
Observational
22,000
Lille, Lyon, Paris, Saint-Herblain
2025-12-01
Not yet open
Hospices Civils de Lyon
Observational
45
Bron, Lyon
2025-12-01
Not yet open
Hospices Civils de Lyon
Observational
150
Lyon
2025-12-01
Recruiting
Eli Lilly and Company
Phase 3
7,140
Bois-Guillaume, Clermont-Ferrand, La Tronche, Le Coudray, Lyon, Mulhouse, Nantes, Nice
2025-12-01
Recruiting
Zai Lab (Shanghai) Co., Ltd.
Phase 3
480
Avignon, Bron, Créteil, Le Mans, Limoges, Lyon, Montpellier, Pierre-Bénite
2025-11-30
Recruiting
Amgen
Phase 3
750
Bordeaux, Caen, Clermont-Ferrand, Le Mans, Lyon, Nice, Paris, Strasbourg
2025-11-28
Recruiting
Hoffmann-La Roche
Phase 3
250
Nantes, Lyon, Montauban, Paris, Poitiers, Strasbourg
2025-11-27
Recruiting
AbbVie
Phase 1
285
Saint-Herblain, Lyon
2025-11-27
Active, closed
Hospices Civils de Lyon
Not applicable
520
Lyon
2025-11-21
Recruiting
Testing Ivonescimab in Combination With Chemotherapy in Advanced or Metastatic Gastric/Gastroesophageal Adenocarcinoma
NCT06846346Metastatic Esophageal Adenocarcinoma, Advanced Esophageal Adenocarcinoma, Metastatic Gastric Adenocarcinoma, Advanced Gastric Adenocarcinoma
DrugsTaxol·Ivonescimab·Folfox·Irinotecan
UNICANCER
Phase 2
88
Lyon, Marseille, Reims, Saint-Herblain
2025-11-20
Recruiting
Observational Multicenter Study in Patients Receiving Chemotherapy and Amivantamab for Metastatic Non-small Cell Lung Cancer
NCT07563205Non-Small Cell Lung Cancer, Non Small Cell Lung Cancer Metastatic, Non Small Cell Lung Cancer NSCLC, Non Small Cell Lung Carcinoma
GFPC Investigation
Observational
100
Aix-en-Provence, Bobigny, Bron, Caen, Créteil, Le Chesnay, Lille, Lyon
2025-11-19
Recruiting
Hospices Civils de Lyon
Not applicable
25
Lyon
2025-11-19
Recruiting
Ono Pharmaceutical Co., Ltd.
Phase 2
144
Besançon, Pessac, Nantes, Marseille, Paris, Lyon, Poitiers
2025-11-18
Recruiting
Summit Therapeutics
Phase 3
600
Bordeaux, Lille, Lyon, Marseille, Montpellier, Nantes, Nice, Paris
2025-11-18
Recruiting
Mondelēz International, Inc.
Not applicable
40
Lyon
2025-11-15
Recruiting
UCB Biopharma SRL
Phase 3
320
Lyon, Nice, Toulon
2025-11-14
Recruiting
Incyte Corporation
Phase 3
250
Argenteuil, Bordeaux, Créteil, Lyon, Nantes, Nice, Paris, Reims
2025-11-13
Recruiting
Nantes University Hospital
Phase 3
478
Chambray-lès-Tours, Lille, Lyon, Marseille, Metz, Montpellier, Nantes, Paris
2025-11-07
Recruiting
Sanofi
Phase 2
208
Antony, Bezannes, Bordeaux, Lyon, Saint-Priest-en-Jarez, Toulouse
2025-11-06
Recruiting
Hospices Civils de Lyon
Not applicable
60
Lyon, Pierre-Bénite
2025-11-05
Recruiting
AbbVie
Phase 3
561
Nice, Lyon, Bordeaux, Nantes, Écully, Créteil, Marseille, Paris
2025-11-05
Recruiting
Centre Leon Berard
Phase 1/2
70
Angers, Bordeaux, Bron, Lille, Lyon, Marseille, Paris, Toulouse
2025-11-04
Not yet open
Assistance Publique - Hôpitaux de Paris
Not applicable
230
Corbeil-Essonnes, Lyon, Montpellier, Paris
2025-11
Not yet open
Fondation Hôpital Saint-Joseph
Not applicable
2,052
Boussy-Saint-Antoine, Lyon, Nantes, Paris, Saint-Cloud, Saint-Etienne, Suresnes, Toulouse
2025-11
Recruiting
AstraZeneca
Phase 3
400
Boulogne-Billancourt, Lyon, Marseille, Saint-Herblain, Toulouse
2025-10-31
Not yet open
New Therapeutic Target for Toxic Epidermal Necrolysis (TEN) Using Anti-CD38+ Monoclonal Antibodies.
NCT07110662Toxic Epidermal Necrolysis, Immunotherapy, Cutaneous Adverse Drug Reactions (CADR)
DrugsDarzalex·Daratumumab
Hospices Civils de Lyon
Phase 1/2
9
Lyon
2025-10-29
Recruiting
Clinical Performance of XPEO-E Liner in SERF Dual-mobility Cups
NCT06917365Total Hip Arthroplasty (THA)
Societe dEtude, de Recherche et de Fabrication
Observational
500
Dijon, Lyon, Saint-Etienne, Strasbourg
2025-10-27
Recruiting
Centre Hospitalier Saint Joseph Saint Luc de Lyon
Not applicable
150
Lyon
2025-10-25
Recruiting
Hoffmann-La Roche
Phase 3
600
Angers, Bobigny, Bron, Caen, Lyon, Montpellier, Nice, Paris
2025-10-24
Recruiting
Daiichi Sankyo
Phase 3
686
Angers, Bordeaux, Boulogne-Billancourt, Bron, Créteil, Dijon, Lille, Lyon
2025-10-24
Recruiting
Septodont
Observational
275
Lyon, Nantes, Paris, Rennes
2025-10-23
Active, closed
Bristol-Myers Squibb
Phase 2/3
470
Lyon, Clermont-Ferrand, Dijon, Besançon, Toulouse, Saint-Cloud, Montpellier, Vandœuvre-lès-Nancy
2025-10-23
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 3
70
Angers, Bordeaux, Dijon, Lyon, Montpellier, Paris, Rouen, Strasbourg
2025-10-21
Recruiting
Institut Claudius Regaud
Not applicable
130
Angers, Bordeaux, Caen, Lille, Lyon, Marseille, Montpellier, Paris
2025-10-21
Recruiting
GlaxoSmithKline
Phase 1/2
47
Lyon, Saint-Herblain, Villejuif
2025-10-20
Recruiting
Upfront Trastuzumab-Deruxtecan Plus Capecitabine and Bevacizumab for Patients With HER-2 Positive Metastatic Colorectal Cancer.
NCT07407465Colorectal Cancer, Colorectal Adenocarcinoma, Rectal Adenocarcinoma, Rectal Cancer, Adenocarcinoma
DrugsTrastuzumab deruxtecan·Capecitabine·Bevacizumab
Gruppo Oncologico del Nord-Ovest
Phase 2
42
Lyon, Marseille, Paris, Reims, St-Malo
2025-10-20
Recruiting
University Hospital, Brest
Not applicable
1,000
Amiens, Brest, Caen, La Roche-sur-Yon, Le Mans, Limoges, Lomme, Lyon
2025-10-17
Recruiting
Centre Jean Perrin
Not applicable
59
Aurillac, Clermont-Ferrand, Lyon, Saint-Etienne
2025-10-13
Recruiting
University Hospital, Clermont-Ferrand
Not applicable
42
Amiens, Clermont-Ferrand, Lille, Lyon, Marseille, Montpellier, Nice, Toulouse
2025-10-13
Recruiting
Gait and Energy Expenditure in Children With Lower Limb Amputation (MAPEDE)
NCT07076602Amputation of Lower Extremity, All Causes
Rennes University Hospital
Observational
48
Berck, Brest, Bron, Dijon, Lyon, Rennes, Saint-Maurice, Valenton
2025-10-13
Recruiting
Centre Hospitalier Universitaire de Nīmes
Not applicable
300
Bordeaux, Lyon, Nîmes
2025-10-10
Recruiting
Design of a Food Preference Assessment Tool for Older Patients in Geriatrics units_DYSPHAGING-PREFERENCES
NCT07205354Hospitalisation in Geriatrics, Swallowing Disorder, Eating Habits
Hospices Civils de Lyon
Observational
209
Lyon, Pierre-Bénite
2025-10-10
Recruiting
Janssen Research & Development, LLC
Phase 1
360
Lyon, Villejuif
2025-10-10
Recruiting
Determinants of the Response to BTK Degraders (BTKd) in Chronic Lymphocytic Leukemia
NCT07099443Chronic Lymphocytic Leukemia, BTK Degraders
Nantes University Hospital
Observational
60
Angers, Bordeaux, Clermont-Ferrand, La Roche-sur-Yon, Lyon, Marseille, Montpellier, Nancy
2025-10-09
Recruiting
GCS Ramsay Santé pour l'Enseignement et la Recherche
Observational
30
Lyon
2025-10-03
Not yet open
Hospices Civils de Lyon
Not applicable
316
Angers, Bordeaux, Epagny METZ Tessy, La Tronche, Lyon, Pierre-Benité, Toulon
2025-10-01
Not yet open
Hospices Civils de Lyon
Observational
50
Lyon
2025-10-01
Active, closed
A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in Europe (PLATINUM EU)
NCT07210463Neuromuscular Agents, Peripheral Nervous System Agents, Physiological Effects of Drugs, Acetylcholine Release Inhibitors
DrugXeomin
Merz Aesthetics GmbH
Phase 3
300
Lyon
2025-10-01
Recruiting
AstraZeneca
Phase 1/2
283
Lyon, Montpellier, Saint-Herblain, Suresnes, Villejuif
2025-10-01
Active, closed
Hospices Civils de Lyon
Phase 2
27
Angers, Bordeaux, Bron, Lille, Lyon, Marseille, Montpellier, Paris
2025-10-01
Recruiting
HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
NCT05745714Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory
DrugsRuxolitinib·Cytarabine·Venetoclax·Dexamethasone
Princess Maxima Center for Pediatric Oncology
Phase 1/2
26
Bordeaux, Lille, Lyon, Marseille, Nantes, Paris
2025-10-01
Not yet open
Hospices Civils de Lyon
Not applicable
516
Ivry-sur-Seine, Lille, Lyon, Nantes, Rennes, Saint-Victor-de-Cessieu, Strasbourg, Toulouse
2025-10-01
Recruiting
HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
NCT05751044Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory
DrugsDasatinib·Cytarabine·Venetoclax·Dexamethasone
Princess Maxima Center for Pediatric Oncology
Phase 1/2
26
Bordeaux, Lille, Lyon, Marseille, Nantes, Paris
2025-10-01
Recruiting
Sanofi
Phase 3
124
Clichy, Dijon, Lille, Lyon, Marseille, Pessac, Suresnes
2025-09-26
Recruiting
Efficacy of Daily IV Administration of Dornase Alfa up to 14 Days Post Subarachnoid Hemorrhage on Functional Independence at 6 Months
NCT06723717Ruptured Aneurysm of Intracranial Artery, SAH (Subarachnoid Hemorrhage), Delayed Cerebral Ischemia
DrugDornase Alfa
Fondation Ophtalmologique Adolphe de Rothschild
Phase 2
304
Grenoble, Lyon, Montpellier, Poitiers, Strasbourg, Suresnes
2025-09-26
Recruiting
Study of the Determinants of Coronary Atherosclerosis in Familial Hypercholesterolemia (ATHERO-FH Study)
NCT06960902Familial Hypercholesterolemias, Atherosclerotic Cardiovascular Disease (ASCVD)
Nantes University Hospital
Not applicable
600
Dijon, Lille, Lyon, Marseille, Nantes, Paris, Rennes, Strasbourg
2025-09-25
Recruiting
Sanofi
Phase 4
218
La Tronche, Lille, Lyon, Marseille, Montpellier, Pessac, Reims
2025-09-22
Recruiting
Sanofi
Phase 3
942
Brest, La Tronche, Le Mans, Lyon, Montpellier, Pessac, Pontoise, Reims
2025-09-16
Not yet open
DOAC Versus VKA in Patients With Non-high-risk APS : Prospective Cohort Study
NCT06884384Antiphospholipid Syndrome (APS), Cohort Study, Thrombotic and Bleeding Events
Central Hospital, Nancy, France
Observational
310
Vandœuvre-lès-Nancy, Amiens, Besançon, Brest, Dijon, Lyon, Metz, Mulhouse
2025-09-15
Not yet open
Shift Hours' Impact on Fatigue and Tracking of Eye Dynamics
NCT07192380Sleep Deprivation, Sleepiness, Eye-Tracking Technology, Radiologists
IMADIS Technologies et Services
Not applicable
40
Lyon
2025-09-15
Recruiting
Hôpital le Vinatier
Not applicable
62
Lyon
2025-09-12
Recruiting
Bristol-Myers Squibb
Phase 2/3
600
Bordeaux, Lyon, Dijon, Toulouse, Montpellier, Rennes, Saint-Herblain, Reims
2025-09-11
Recruiting
Archean Technologies
Not applicable
100
Lyon, Paris, Toulouse
2025-09-10
Recruiting
Hospices Civils de Lyon
Observational
50
Lyon
2025-09-09
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
140
Lyon, Montpellier, Paris, Reims, Strasbourg, Villejuif
2025-09-03
Recruiting
University Hospital, Toulouse
Observational
200
Amiens, Lille, Lyon, Montpellier, Nantes, Nice, Rouen, Toulouse
2025-09-03
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company
Phase 3
10,450
Dijon, Epagny Metz-Tessy, La Tronche, Lille, Lyon, Nantes, Nice, Paris
2025-09-02
Recruiting
Janssen Research & Development, LLC
Phase 3
1,203
Bordeaux, Brest, Dijon, Lille, Lyon, Paris, Pierre-Bénite, Saint-Herblain
2025-09-02
Recruiting
Centre Hospitalier Universitaire de Saint Etienne
Not applicable
212
Clermont-Ferrand, Grenoble, Lyon, Saint-Etienne
2025-09-02
Recruiting
Ustekinumab in BEhçet's Syndrome STudy
NCT07244614Behçet's Syndrome (BS)
Groupe français d'étude des Maladies Inflammatoires de loeil
Observational
208
Bordeaux, Créteil, Lyon, Melun, Paris, Rouen
2025-09-01
Not yet open
Evaluation of Efficacy and Safety De-escalation Versus Standard Adjuvant Chemotherapy in Patients With Low Risk Localized Gastroesophageal Adenocarcinoma
NCT06933966Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma, Non Metastatic Disease
Centre Leon Berard
Phase 2
120
Lyon, Marseille, Paris
2025-09-01
Not yet open
Community Screening and Management of Hepatitis B, C and Delta in the Mongolian Population Living in France
NCT07038863HEPATITIS C (HCV), Hepatitis B Virus (HBV), Hepatitis D, Hepatocellular Carcinoma (HCC)
Hospices Civils de Lyon
Not applicable
2,000
Annecy, Bordeaux, Clermont-Ferrand, Créteil, Grenoble, Lille, Lyon, Rennes
2025-09-01
Not yet open
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2
162
Amiens, Besançon, Caen, La Roche-sur-Yon, Lille, Lyon, Paris, Pessac
2025-09
Not yet open
Assistance Publique - Hôpitaux de Paris
Phase 2/3
526
Clermont-Ferrand, Le Kremlin-Bicêtre, Lille, Lyon, Marseille, Paris, Rouen, Toulouse
2025-09
Not yet open
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2
60
Avignon, Besançon, Levallois-Perret, Lyon, Paris, Pessac, Poitiers, Toulouse
2025-09
Not yet open
Low Powered Colorectal Anastomosis After Rectal Excision (OASIS)
NCT07146334Rectal Cancer, Surgery Indication
Bordeaux Colorectal Institute
Observational
400
Besançon, Bordeaux, Le Kremlin-Bicêtre, Lyon, Paris, Rouen
2025-09
Recruiting
Meyer Children's Hospital IRCCS
Phase 3
40
Lyon
2025-08-29
Recruiting
Mirum Pharmaceuticals, Inc.
Phase 3
172
Clermont-Ferrand, Clichy, Créteil, La Tronche, Le Chesnay, Lille, Limoges, Lyon
2025-08-27
Recruiting
Relay Therapeutics, Inc.
Phase 3
540
Angers, Besançon, Bobigny, Bordeaux, Caen, Lyon, Marseille, Montpellier
2025-08-26
Recruiting
University of Minnesota
Observational
1,500
Lyon, Paris
2025-08-25
Active, closed
Amgen
Phase 3
350
Créteil, Lyon, Marseille, Paris, Saint-Herblain, Toulon, Toulouse
2025-08-18
Recruiting
University Hospital, Limoges
Not applicable
140
Limoges, Lyon
2025-08-12
Recruiting
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Phase 1
15
Avignon, Besançon, Brest, Lille, Lyon, Pessac, Poitiers, Reims
2025-08-08
Active, closed
Validation of a Questionnaire in the French Language for the Patient Experience in Radiotherapy
NCT07133594Validation RTEQ (RadioTherapy Experience Questionnaire) in French, Patients Requiring Radiotherapy
Centre Leon Berard
Not applicable
320
Lyon
2025-08-07
Recruiting
Pfizer
Phase 3
400
Rennes, Brest, Saint-Cloud, Montpellier, Vandœuvre-lès-Nancy, Bron, Lyon, Pierre-Bénite
2025-08-05
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
227
Angers, Bordeaux, Caen, Créteil, Grenoble, Lille, Lyon, Montpellier
2025-08-05
Recruiting
HOPE Against Cancer Recurrence in HCC
NCT06717919Liver Transplantation, HCC, Oncological Outcomes
Philipp Dutkowski
Phase 4
220
Lyon
2025-08-01
Recruiting
Amgen
Phase 1
434
Lyon, Villejuif
2025-07-31
Active, closed
Vir Biotechnology, Inc.
Phase 3
150
Bobigny, Clichy, Créteil, Le Chesnay, Limoges, Lyon, Montpellier, Pessac
2025-07-30
Active, closed
A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
NCT07038369Advanced Solid Tumors, Breast Cancer, Breast Carcinoma, Breast Neoplasms
DrugATV-1601
Atavistik Bio, Inc
Phase 1
134
Lyon
2025-07-29
Recruiting
Free for Weaning ECMO vs Respiratory Driven Study
NCT06876415ARDS (Acute Respiratory Distress Syndrome)
Assistance Publique Hopitaux De Marseille
Not applicable
50
Lyon, Marseille, Nice, Paris
2025-07-29
Recruiting
A Study of LY4175408 in Participants With Advanced Cancer
NCT07046923Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma, Endometrial Neoplasms, Neoplasm Metastasis
DrugsCisplatin·Carboplatin·Pembrolizumab
Eli Lilly and Company
Phase 1
240
Lyon, Villejuif
2025-07-28
Recruiting
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
NCT07094204Solid Tumor, Non-Small-Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma, Colorectal Cancer
DrugPanitumumab
Astellas Pharma Inc
Phase 1
404
Bordeaux, Lyon, Pierre-Bénite, Villejuif
2025-07-25
Recruiting
GCS Ramsay Santé pour l'Enseignement et la Recherche
Not applicable
448
Lyon
2025-07-25
Recruiting
Amgen
Phase 3
12,800
Besançon, Dijon, Grenoble, Le Coudray, Le Creusot, Lyon, Marseille, Nice
2025-07-25
Recruiting
Hospices Civils de Lyon
Not applicable
482
Bordeaux, Dijon, Grenoble, Jossigny, Lille, Lyon, Marseille, Nantes
2025-07-25
Recruiting
Centre Hospitalier Universitaire de Nice
Phase 2
40
Nice, Lyon, Marseille, Martigues, Saint-Etienne, Toulon, Villeurbanne
2025-07-22
Recruiting
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
NCT06943755Pancreatic Neuroendocrine Tumor (pNET), Extra-Pancreatic Neuroendocrine Tumor (epNET)
DrugsZanzalintinib·Everolimus
Exelixis
Phase 2/3
440
Caen, Clichy, Lille, Lyon, Marseille, Montpellier, Nantes, Rennes
2025-07-21
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,000
Brest, Lyon, Rouen, Villejuif
2025-07-21
Recruiting
Teleflex
Not applicable
150
Lyon, Essey-lès-Nancy, Saint-Laurent-du-Var, Paris
2025-07-18
Recruiting
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
NCT06765109Non-small Cell Lung Cancer, Anaplastic Lymphoma Kinase-positive
DrugsNeladalkib·Alectinib
Nuvalent Inc.
Phase 3
450
Angers, Bordeaux, Caen, Lyon, Marseille, Montpellier, Nantes, Paris
2025-07-17
Recruiting
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
NCT06570798Systemic Lupus Erythematosus, Active Refractory Rheumatoid Arthritis
DrugsUplizna·Inebilizumab·Blinatumomab
Amgen
Phase 2
220
Le Kremlin-Bicêtre, Lille, Lyon, Lyon Cédex 3, Marseille, Paris, Strasbourg, Toulouse
2025-07-16
Recruiting
Hospices Civils de Lyon
Not applicable
80
Bron, Lyon
2025-07-09
Recruiting
Hospices Civils de Lyon
Not applicable
523
Clermont-Ferrand, Épagny, La Tronche, Lyon, Pierre-Bénite, Saint-Etienne
2025-07-09
Recruiting
Evaluation of Facial HA Dermal Fillers in Real-Life Conditions
NCT07255261Lips Enhancement, Perioral Wrinkles, Nasolabial Fold Wrinkles, Cheek Augmentation
Symatese
Not applicable
460
Arras, Lyon, Palaiseau, Paris, Saint-Maur-des-Fossés
2025-07-02
Recruiting
National Institute of Oncology, Hungary
Not applicable
250
Lyon, Nancy, Nice
2025-07-01
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
3,149
Lyon, Paris
2025-07-01
Recruiting
Impact of Nutritional Management on the Frailty of Patients Waiting for Liver Transplantation (Via the LFI Tool)
NCT06911619Fragility, Cirrhosis, Hepatic Transplantation, Undernutrition
Hospices Civils de Lyon
Not applicable
210
Lyon
2025-06-30
Recruiting
GCS Ramsay Santé pour l'Enseignement et la Recherche
Not applicable
216
Lyon, Quint-Fonsegrives
2025-06-30
Recruiting
MedSIR
Phase 2
200
Caen, Lyon, Marseille, Paris, Saint-Priest-en-Jarez
2025-06-30
By invitation
MoonLake Immunotherapeutics AG
Phase 3
835
Brest, Lyon, Saint-Mandé, Saint-Priest-en-Jarez
2025-06-27
Recruiting
Using an Intervention Adapted to the Health Literacy Level to Improve Adherence to Medical Recommendations
NCT03951467Acute Decompensated Heart Failure, Acute Myocardial Infarction
Hospices Civils de Lyon
Not applicable
300
Bron, Lyon, Pierre-Bénite, Saint-Didier-au-Mont-d'Or
2025-06-26
Recruiting
Centre Hospitalier Universitaire de Saint Etienne
Phase 2
334
Clermont-Ferrand, Lyon, Marseille, Metz, Paris, Pierre-Bénite, Saint-Etienne
2025-06-26
Recruiting
Anterior Cruciate Ligament Reconstruction
NCT06099600Ligament Rupture
GCS Ramsay Santé pour l'Enseignement et la Recherche
Not applicable
84
Lyon
2025-06-26
Recruiting
GCS Ramsay Santé pour l'Enseignement et la Recherche
Not applicable
100
Lyon
2025-06-25
Recruiting
INNODIA Family & Friends Early-Stage T1D Detection Protocol
NCT07118098Type 1 Diabetes (T1D), Pre Diabetes
INNODIA iVZW
Observational
30,000
Angers, Bobigny, Bondy, Corbeil-Essonnes, Lyon, Nice, Paris, Vandœuvre-lès-Nancy
2025-06-25
Recruiting
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
NCT07020221Pancreatic Ductal Adenocarcinoma, Non Small Cell Lung Cancer, Colorectal Cancer, Solid Tumor, Adult
DrugsRepaglinide·VS-7375·Defactinib·Erbitux
Verastem, Inc.
Phase 1/2
616
Lyon, Marseille, Paris
2025-06-24
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 3
134
Bordeaux, Boulogne-Billancourt, Caen, Créteil, Grenoble, Le Kremlin-Bicêtre, Lyon, Melun
2025-06-24
Recruiting
Enterra Medical, Inc.
Not applicable
148
Colombes, Lyon, Pessac, Rouen
2025-06-23
Recruiting
GlaxoSmithKline
Phase 3
981
Saint-Quentin, Marseille, Amiens, Blois, Caen, La Tronche, Lyon, Nice
2025-06-20
By invitation
BioMarin Pharmaceutical
Phase 3
140
Lyon, Marseille, Paris, Toulouse
2025-06-20
Active, closed
Prediction of Lung Transplant Outcome
NCT07356752Graft Dysfunction, Lung Transplantation, Chronic Lung Allograft Dysfunction (CLAD), Chronic Rejection of Lung Transplant
Hopital Foch
Not applicable
4,200
Paris, Strasbourg, Talence, Grenoble, Le Plessis-Robinson, Lyon, Nantes, Suresnes
2025-06-17
Recruiting
First-in-human Trial of STC-1010, an Immunotherapy, in Patients With Unresectable Locally Advanced or Metastatic Colorectal Cancer
NCT06934538Unresectable Metastatic Colorectal Cancer, Unresectable Locally Advanced Colorectal Cancer
Brenus Pharma
Phase 1/2
90
Bordeaux, Dijon, Lyon, Montpellier, Poitiers, Villejuif
2025-06-17
Recruiting
Nantes University Hospital
Not applicable
362
Angers, Bordeaux, Grenoble, Lyon, Marseille, Nantes, Paris, Rennes
2025-06-17
Recruiting
GCS Ramsay Santé pour l'Enseignement et la Recherche
Observational
200
Lyon, Saint-Etienne
2025-06-17
Recruiting
Phase 1/2 Study of ABO-101 in Primary Hyperoxaluria Type 1 (redePHine)
NCT06839235Primary Hyperoxaluria Type 1 (PH1)
Arbor Biotechnologies
Phase 1/2
23
Lyon
2025-06-16
Recruiting
Grupo Espanol de Tumores Neuroendocrinos
Phase 3
166
Caen, Dijon, Lille, Lyon, Marseille, Clichy, Paris, Villejuif
2025-06-12
Recruiting
GlaxoSmithKline
Phase 1/2
85
Lyon, Villejuif
2025-06-12
Active, closed
Merck Sharp & Dohme LLC
Phase 2
149
Lyon, Bordeaux, Toulon, Paris
2025-06-09
Recruiting
Boehringer Ingelheim
Phase 3
1,755
Amiens, Créteil, Lille, Lyon, Montpellier, Nice, Paris, Pessac
2025-06-09
Recruiting
Calico Life Sciences LLC
Phase 2
240
Lyon, Brest, Toulouse, Marseille, Paris
2025-06-09
Recruiting
First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma
NCT06797999Metastatic Soft Tissue Sarcoma, Unresectable Soft Tissue Sarcoma
Adcendo ApS
Phase 1/2
270
Paris, Lyon
2025-06-05
Recruiting
University Hospital, Grenoble
Observational
35
Lyon, Pierre-Bénite, Strasbourg, La Tronche, Montpellier, Toulouse, Paris
2025-06-04
Not yet open
Centre Hospitalier Universitaire de Nīmes
Not applicable
425
Montpellier, Lyon
2025-06-01
Not yet open
Pilot Study of PEnile TRAnsplantation - Vascularized Composite Allografts
NCT06781606Adults with Traumatic Penile Severe Defects, Congenital Penile Defects, Micropenis
Hospices Civils de Lyon
Not applicable
3
Bordeaux, Lille, Lyon, Marseille, Montpellier, Pierre-Bénite, Suresnes, Toulouse
2025-06-01
Not yet open
Non-medicinal Technique and Dyspnea in Weaning Patients
NCT06926231Difficult Mechanical Ventilation Weaning, Spontaneous Breathing Trial, Dyspnea
Hospices Civils de Lyon
Not applicable
82
Bourg-en-Bresse, Clermont-Ferrand, La Tronche, Lyon, Pierre-Bénite
2025-06-01
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
50
Bordeaux, Marseille, Nantes, Lyon, Paris
2025-05-26
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,123
Marseille, Caen, Plérin, Bordeaux, Toulouse, Saint-Cloud, Saint-Herblain, Lyon
2025-05-22
Recruiting
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
NCT06901531Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
DrugsZolbetuximab·Adrucil·Capecitabine·Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 3
500
Bordeaux, Brest, Caen, Carassonne, Dijon, Lille, Lyon, Montpellier
2025-05-22
Recruiting
Phosphorus-31 Spectroscopy in Phosphate Diabetes
NCT06921720Phosphate Diabetes, X-linked Hypophosphatemia
Hospices Civils de Lyon
Not applicable
65
Bron, Lyon
2025-05-16
Active, closed
Amgen
Phase 1
29
Bordeaux, Lyon, Toulouse, Villejuif
2025-05-16
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Phase 4
50
Angers, Dijon, Lyon, Paris, Toulouse, Tours, Villejuif
2025-05-16
Not yet open
Centre Leon Berard
Not applicable
50
Lyon
2025-05-15
Recruiting
Perioperative Durvalumab With Neoadjuvant ddMVAC in Patients With Muscle-Invasive Bladder Cancer (NIAGARA-2)
NCT06960577Urinary Bladder Neoplasms, Immune Checkpoint Inhibitors, Methotrexate, Vinblastine
DrugsVinblastine·Methotrexate·Doxorubicin·Durvalumab
AstraZeneca
Phase 2
150
Angers, Bordeaux, Chambray-lès-Tours, Dijon, Lille, Lyon, Marseille, Montpellier
2025-05-15
Recruiting
Surgical vs Transcatheter Aortic Valve Replacement in YOUNG Patients
NCT06861361Symptomatic Severe Aortic Stenosis
Ceric Sàrl
Not applicable
1,180
Lille, Lyon, Massy, Rouen, Toulouse
2025-05-15
Active, closed
Boehringer Ingelheim
Phase 1
91
Lille, Lyon, Marseille, Villejuif
2025-05-14
Recruiting
Hospices Civils de Lyon
Not applicable
17
Lyon
2025-05-13
Recruiting
ANRS, Emerging Infectious Diseases
Phase 1/2
238
Dijon, Lyon, Paris, Saint-Priest-en-Jarez, Tours
2025-05-09
Recruiting
AstraZeneca
Phase 3
1,220
Clichy, Lille, Lyon, Montpellier, Nantes, Nice, Pessac, Rennes
2025-05-06
Recruiting
"Continuous Positive Airway Pressure on Venovenous extracorporeaL Membrane Oxygenation for Acute respIratory Distress syndrOme"
NCT06814340Acute Respiratory Distress Syndrome, Extracorporeal Membrane Oxygenation Complication
Assistance Publique - Hôpitaux de Paris
Phase 3
280
Bobigny, Bordeaux, Créteil, Lyon, Marseille, Metz, Nancy, Orléans
2025-05-06
Active, closed
Agios Pharmaceuticals, Inc.
Phase 2
59
Lyon, Toulouse, Créteil
2025-05-01
Recruiting
Institut Cancerologie de l'Ouest
Phase 3
84
Brest, Caen, Chambray-lès-Tours, Dijon, Le Havre, Lyon, Rennes, Saint-Herblain
2025-04-29
Recruiting
Fondation Ophtalmologique Adolphe de Rothschild
Phase 3
128
Bordeaux, Garches, Lille, Lyon, Nice, Paris, Strasbourg, Toulouse
2025-04-29
Active, closed
Eli Lilly and Company
Phase 3
905
Caen, Corbeil-Essonnes, Le Creusot, Lyon, Marseille, Montpellier, Nantes, Pontoise
2025-04-25
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
200
Annecy, Clermont-Ferrand, Lyon, Paris
2025-04-24
Recruiting
TTV-based mAnagement Of Long-term ImmunosuppreSsion in Kidney Transplantation
NCT06829719Infection, Cancer, Rejection, Kidney Transplantation
DrugBiological tests
Hospices Civils de Lyon
Not applicable
600
Bordeaux (France), Lyon, Strasbourg (france), Toulouse (France)
2025-04-23
Recruiting
Hospices Civils de Lyon
Not applicable
30
Lyon
2025-04-22
Recruiting
Preoperative Magnetic Tracking in Breast Surgery in France: French Medical-economic Study.
NCT06906601Breast Cancer, Medico-economic Impact, Breast Cancer Surgery
Centre Leon Berard
Observational
772
Lyon, Nancy, Pontoise, Reims, Rennes, Villejuif
2025-04-15
Recruiting
University Hospital, Limoges
Phase 4
162
Besançon, Clichy, Dijon, Grenoble, Lille, Limoges, Lyon, Marseille
2025-04-15
Recruiting
Institut du Cancer de Montpellier - Val d'Aurelle
Not applicable
254
Dijon, Nîmes, Bordeaux, Montpellier, Angers, Lyon
2025-04-15
Recruiting
Study of the Link Between MASH ( Metabolic Dysfunction-Associated Steatohepatitis) and MAMs (Mitochondria-Associated Membranes ) Alteration in Patients Undergoing Bariatric Surgery - MAMBA
NCT06868992Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction-Associated Steatohepatitis, Sleeve Gastrectomy, Gastric Bypass Surgery
Hospices Civils de Lyon
Observational
20
Lyon, Pierre-Bénite
2025-04-15
Recruiting
Pyxis Oncology, Inc
Phase 1/2
220
Bordeaux, Lyon, Marseille, Villejuif
2025-04-15
Not yet open
Hospices Civils de Lyon
Observational
1,500
Lyon
2025-04-15
Recruiting
Hospices Civils de Lyon
Phase 2
58
Bordeaux, Brest, Bron, Caen, Clermont-Ferrand, Grenoble, Lyon, Nantes
2025-04-11
Active, closed
University Hospital, Tours
Observational
80
Brest, Clermont-Ferrand, Lille, Limoges, Lyon, Nice, Tours
2025-04-11
Recruiting
Société des Produits Nestlé (SPN)
Not applicable
400
Amiens, Caen, Grenoble, Lyon, Rouen, Tours
2025-04-10
Recruiting
Impaired Type I IFN Immunity Due to Autoantibodies or a Genetic Defect: a Prospective National Cohort
NCT06762002Immunology, Allergy, Genetic Diseases, Infectious Diseases
Institut National de la Santé Et de la Recherche Médicale, France
Observational
500
Lille, Lyon, Montpellier, Paris, Tours
2025-04-09
Recruiting
Centre Hospitalier Saint Joseph Saint Luc de Lyon
Not applicable
30
Créteil, Lyon
2025-04-07
Recruiting
Institut Claudius Regaud
Not applicable
150
Angers, Bordeaux, Caen, Lille, Lyon, Marseille, Montpellier, Nantes
2025-04-07
Recruiting
Gilead Sciences
Phase 3
695
Angers, Créteil, La Tronche, Lyon, Marseille, Paris, Pessac, Rennes
2025-04-04
Recruiting
Resilience
Phase 3
1,458
Aix-en-Provence, Aurillac, Bayonne, Caen, Clermont-Ferrand, La Tronche, Lille, Lyon
2025-04-01
Not yet open
Prevalence of Problematic Use of Social Media
NCT06798480Social Networks, Addiction
Hospices Civils de Lyon
Observational
1,000
Lyon
2025-04-01
Recruiting
Centre Hospitalier Saint Joseph Saint Luc de Lyon
Not applicable
574
Lyon
2025-04-01
Recruiting
University Hospital, Clermont-Ferrand
Not applicable
1,000
Clermont-Ferrand, Grenoble, Lyon, Saint-Etienne
2025-04-01
Recruiting
Madeleine Bezault
Phase 2
80
Clermont-Ferrand, Créteil, Le Kremlin-Bicêtre, Lille, Lyon, Marseille, Montpellier, Nancy
2025-03-31
Recruiting
Ultra Processed Foods Consumption and Impact in Rheumatic Diseases.
NCT06776965Rheumatoid Arthritis, Spondyloarthritis, Osteoarthritis
Hospices Civils de Lyon
Observational
240
Lyon
2025-03-31
Recruiting
Laboratoires URGO
Not applicable
210
Paris, Lyon
2025-03-29
Recruiting
Prescient Therapeutics, Ltd.
Phase 2
115
Bordeaux, Lyon, Paris
2025-03-28
Recruiting
AstraZeneca
Phase 3
600
Besançon, Bordeaux, Caen, Clermont-Ferrand, Lyon, Montpellier, Nice, Paris
2025-03-27
Recruiting
Daiichi Sankyo
Phase 3
510
Avignon, Brest, Dijon, Lille, Lyon, Marseille, Montpellier, Nantes
2025-03-27
Recruiting
Rennes University Hospital
Phase 4
400
Chambray-lès-Tours, Clichy, Lille, Lyon, Montpellier, Pessac, Rennes, Villejuif
2025-03-26
Recruiting
AstraZeneca
Phase 2
540
Brest, Créteil, Lyon, Marseille, Pessac, Strasbourg, Suresnes
2025-03-26
Recruiting
AstraZeneca
Phase 3
990
Brest, Lyon, Marseille, Montpellier, Paris, Pessac, Saint-Herblain
2025-03-25
Recruiting
UNICANCER
Phase 2
73
Amiens, Angers, Avignon, Besançon, Cholet, Dijon, Lyon, Montpellier
2025-03-21
Active, closed
Novartis Pharmaceuticals
Phase 3
565
Nice, Brest, La Rochelle, Lyon, Reims, Rouen, Toulouse
2025-03-20
Recruiting
ANRS, Emerging Infectious Diseases
Not applicable
100
Lyon, Paris
2025-03-20
Recruiting
Daiichi Sankyo
Phase 3
582
Bordeaux, Dijon, Lille, Lyon, Montpellier, Nantes, Paris, Rennes
2025-03-19
Recruiting
Validation of a Rapid Screening Tool for Anxiety-depressive Disorders in Children, Adolescents and Young Adults Treated in Oncology. Multicenter Study.
NCT07117058Generalized Anxiety, Introspective & Anxiety-Prone Patient, Depression, Anxiety, Survivors of Childhood Cancer
Centre Hospitalier Universitaire de Saint Etienne
Observational
545
Angers, Caen, Grenoble, Lyon, Nice, Rouen, Saint-Etienne
2025-03-18
Recruiting
Study of Sleep Disorders in Prodromal and Definite Parkinsons Disease
NCT06582121Parkinson Disease, REM Sleep Behavior Disorder (iRBD)
Assistance Publique - Hôpitaux de Paris
Not applicable
457
Clermont-Ferrand, Lille, Lyon, Nantes, Nîmes, Paris
2025-03-18
Recruiting
Hospices Civils de Lyon
Not applicable
50
Lyon
2025-03-18
Active, closed
Hedia ApS
Not applicable
154
Angers, Lyon, Nantes, Nîmes, Paris, Poitiers
2025-03-17
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,000
Lyon, Limoges, Montpellier, Saint-Herblain, Reims, Rouen, Toulon, Paris
2025-03-16
Not yet open
Hospices Civils de Lyon
Not applicable
720
Lyon
2025-03-15
Active, closed
Ipsen
Phase 1/2
42
Lyon, Paris, Villejuif
2025-03-14
Recruiting
Insel Gruppe AG, University Hospital Bern
Phase 4
906
Bordeaux, Grenoble, Lille, Lyon, Montpellier, Nancy, Paris, Perpignan
2025-03-14
Active, closed
Hoffmann-La Roche
Phase 4
274
Bordeaux, Lyon, Paris, Saint-Cyr-sur-Loire, Saint-Jean
2025-03-14
Recruiting
Hospices Civils de Lyon
Not applicable
66
Annecy, Chambéry, Lyon, Montpellier, Nîmes, Toulouse
2025-03-14
Not yet open
Somesthesia in Cancer Patients: Variability and Influence on Eating Experience
NCT06803381Digestive Cancers, Breast Cancer, Gynecologic Cancer, Lung Cancer
Hospices Civils de Lyon
Observational
96
Lyon
2025-03-13
Recruiting
177Lu-DOTATATE for Recurrent Meningioma
NCT06326190Recurrent Meningioma
DrugsLuTate·Lutathera
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
136
Lyon, Marseille, Rennes, Toulouse, Vandœuvre-lès-Nancy, Villejuif
2025-03-10
Recruiting
GCS Ramsay Santé pour l'Enseignement et la Recherche
Observational
100
Lyon
2025-03-10
Active, closed
Hospices Civils de Lyon
Observational
20
Lyon
2025-03-10
Recruiting
Capsaicin in Digital Osteoarthritis Versus Control
NCT06444919Osteoarthritis Hand, Neuropathic Pain
DrugCapsaicin
University Hospital, Clermont-Ferrand
Phase 4
120
Clermont-Ferrand, Lyon, Paris, Saint-Etienne
2025-03-07
Active, closed
A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
NCT06521567Melanoma, Hodgkin Lymphoma, High and Low Grade Glioma, Glioblastoma Multiforme (GBM)
DrugsCobolimab·Dostarlimab
GlaxoSmithKline
Phase 1/2
83
Bordeaux, Lyon, Paris, Strasbourg, Villejuif
2025-03-06
Recruiting
GlaxoSmithKline
Phase 1/2
305
Lyon, Marseille, Montpellier, Pierre-Bénite, Villejuif
2025-03-04
Recruiting
AstraZeneca
Phase 3
840
Bordeaux, Caen, Clermont-Ferrand, Dijon, Lyon, Marseille, Poitiers, Rennes
2025-03-01
Not yet open
Arginin-stimulated Copeptin in Polyuria-polydipsia Syndrome in Children
NCT06604975Primary Polydipsia, Central Diabetes Insipidus, Nephrogenic Diabetes Insipidus
Assistance Publique Hopitaux De Marseille
Not applicable
155
Angers, Bordeaux, Lille, Lyon, Marseille, Montpellier, Nantes, Nice
2025-03
Recruiting
Centre Hospitalier Universitaire de Besancon
Not applicable
226
Besançon, Bordeaux, Grenoble, Lille, Lyon, Marseille, Nancy, Nantes
2025-03
Recruiting
Incyte Corporation
Phase 3
600
Antony, Bordeaux, Brest, Créteil, Lyon, Marseille, Nantes, Nice
2025-02-28
Recruiting
Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
NCT06517875Primary Myelofibrosis, Myelofibrosis; Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis
DrugsMomelotinib·Reblozyl·Luspatercept
GlaxoSmithKline
Phase 2
68
Angers, Brest, Lyon, Nice, Nîmes, Paris, Poitiers
2025-02-28
Recruiting
Summit Therapeutics
Phase 3
780
Nantes, Avignon, Brest, Créteil, Lille, Lyon, Marseille, Paris
2025-02-27
Recruiting
Daiichi Sankyo
Phase 3
726
Avignon, Brest, Dijon, Grenoble, Lille, Lyon, Montpellier, Nantes
2025-02-27
Recruiting
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
NCT06823167Solid Malignancies, Hematologic Malignancies
Immunome, Inc.
Phase 1
190
Lyon, Paris, Villejuif
2025-02-26
Recruiting
Lymphocyte-Sparing And Radio-Immunotherapy in Head and Neck Carcinoma
NCT06706401Oropharynx Cancer, Larynx Cancer, Hypopharynx Cancer, Primary Head and Neck Tumor
DrugsVesanoid·ATRA·Cetuximab·Cisplatin
Centre Leon Berard
Phase 3
460
Lyon, Vandœuvre-lès-Nancy, Villejuif, Angers, Lille, Nice, Paris, Reims
2025-02-20
Recruiting
Novartis Pharmaceuticals
Phase 2
20
Bordeaux, Lille, Lyon, Nantes, Paris, Vandœuvre-lès-Nancy
2025-02-18
By invitation
Preventive Remediation for OptiMal StudentS (PROMESS-Group)
NCT07030751Health Behavior, Health-Related Behavior
Research on Healthcare Performance Lab U1290
Not applicable
97
Lyon
2025-02-18
Recruiting
Novo Nordisk A/S
Phase 3
510
Bobigny, Bordeaux, Créteil, Grenoble, Lyon, Paris, Rouen
2025-02-17
Recruiting
University Hospital, Clermont-Ferrand
Not applicable
250
Clermont-Ferrand, Grenoble, Le Puy-en-Velay, Lyon, Saint-Etienne, Valence, Villejuif
2025-02-12
Recruiting
Association pour la promotion de la recherche en maladies infectieuses et tropicales dans le Loiret
Observational
120
Caen, La Roche-sur-Yon, Lyon, Nantes, Niort, Orléans, Paris, Poitiers
2025-02-11
Recruiting
Hospices Civils de Lyon
Observational
40
Lyon
2025-02-10
By invitation
Impact of a Physical Activity Program on the Mental Health of Medical Students.
NCT06822075Health Behavior, Health Related Physical Fitness, Mental Health, Sedentary Behaviors
Research on Healthcare Performance Lab U1290
Not applicable
50
Lyon
2025-02-06
Recruiting
Maze Therapeutics
Phase 2
74
Créteil, Lille, Lyon, Paris, Saint-Ouen
2025-02-05
Recruiting
LEO Pharma
Phase 3
90
Antony, Lyon, Nice, Paris
2025-02-05
By invitation
Occlutech International AB
Observational
200
Katowice, Lyon, Marseille, Paris
2025-02-05
Recruiting
Assessment of Dental Pathologies Using Digital Tools
NCT07205588Dental Caries (Diagnosis), Dental Plaque (Diagnosis), Periodontitis
Recherche Clinique en Odontologie (ReCOL)
Observational
350
Châtillon, Colombes, La Chapelle-sur-Erdre, Landivisiau, Latresne, Les Côtes-d'Arey, Lyon, Marseille
2025-02-04
Recruiting
LEOPARD Training and Validation Data Collection Study
NCT06675604Decompensated Liver Cirrhosis, Primary Biliary Cholangitis, Primary Sclerosing Cholangitis, Hepato-cellular Carcinoma
Assistance Publique - Hôpitaux de Paris
Observational
4,500
Besançon, Chambray-lès-Tours, Clichy, Créteil, Dijon, Lille, Lyon, Marseille
2025-02-04
Recruiting
Bristol-Myers Squibb
Phase 1/2
416
Nice, Bordeaux, Lyon, Marseille, Caen, Montpellier, Villejuif, Paris
2025-02-04
Recruiting
Centre Hospitalier Universitaire de Nice
Phase 3
120
Besançon, Bordeaux, Caen, Créteil, Lyon, Marseille, Nice, Nîmes
2025-02-04
Recruiting
Alcediag
Not applicable
450
Erstein, Issy-les-Moulineaux, La Roche-sur-Foron, Lyon, Montrond-les-Bains, Paris, Ville-d'Avray
2025-02-03
Active, closed
Medico-economic Analysis of Clinical Pharmacy Activities
NCT07133152Stroke Geriatrics Acute Coronary Syndrome Orthogeriatric
Hospices Civils de Lyon
Observational
240
Bron, Hyères, Lyon, Oullins, Villeurbanne
2025-02-01
Not yet open
Hospices Civils de Lyon
Observational
200
Lyon
2025-02-01
Active, closed
Hospices Civils de Lyon
Observational
711
Lyon
2025-02-01
Recruiting
GCS Ramsay Santé pour l'Enseignement et la Recherche
Not applicable
25
Lyon
2025-01-29
Recruiting
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
NCT06788990Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
DrugsFicerafusp alfa·Keytruda·Pembrolizumab
Bicara Therapeutics
Phase 2/3
650
Amiens, Bordeaux, Lille, Lyon, Paris, Rennes, Saint-Grégoire, Strasbourg
2025-01-28
Recruiting
UNICANCER
Phase 2
198
Angers, Besançon, Bordeaux, Caen, Clermont-Ferrand, Dijon, Limoges, Lyon
2025-01-27
Active, closed
Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors
NCT06781983Advanced or Metastatic Solid Tumors
Innate Pharma
Phase 1
145
Lyon, Villejuif
2025-01-24
Active, closed
Institut de Recherches Internationales Servier
Phase 1/2
51
Lyon, Paris, Toulouse
2025-01-22
Recruiting
Theravia
Phase 2
50
Créteil, Jossigny, Le Kremlin-Bicêtre, Lyon, Paris, Saint-Denis
2025-01-21
Recruiting
TAR-0520 Gel in EGFR Inhibitor-induced Folliculitis
NCT06818058EGFR Inhibitor-associated Rash
Tarian Pharma
Phase 2
60
Lyon, Marseille, Nice
2025-01-20
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
290
Bordeaux, Boulogne-Billancourt, Brest, Cergy-Pontoise, Créteil, Dijon, Lyon, Marseille
2025-01-20
Active, closed
argenx
Phase 3
631
Marseille, Orléans, Lyon, Paris
2025-01-15
Recruiting
ETOP IBCSG Partners Foundation
Phase 3
290
Angers, Bordeaux, Le Mans, Lyon
2025-01-15
Not yet open
University Hospital, Bordeaux
Not applicable
252
Bordeaux, Boulogne-Billancourt, Castelnau-le-Lez, Dijon, Grenoble, Lyon, Nice, Paris
2025-01-15
Recruiting
Centre Leon Berard
Not applicable
236
Angers, Besançon, Bordeaux, Caen, Lille, Lyon, Nancy, Nice
2025-01-14
Recruiting
Novo Nordisk A/S
Phase 3
480
Créteil, Lyon, Paris
2025-01-10
Recruiting
Galimedix Therapeutics Inc
Phase 2
110
Bordeaux, Lyon, Marseille, Paris, Tours
2025-01-10
Active, closed
Artificial Intelligence for Respiratory Infections SEverity Prediction
NCT07047768Infectious Respiratory Diseases, Hospitalized Patients, Adult Patients
Hospices Civils de Lyon
Observational
52,000
Lyon
2025-01-07
Active, closed
Daiichi Sankyo
Phase 2
335
Caen, Dijon, Lille, Lyon, Paris, Plérin, Saint-Herblain, Toulouse
2025-01-06
Active, closed
Hospices Civils de Lyon
Observational
35,000
Lyon
2025-01-02
Not yet open
Hospices Civils de Lyon
Phase 2
12
Lyon
2025-01-01
Active, closed
Impact of PREMs in the Shared Decision Process for Renal Replacement Treatment Methods.
NCT06819345Chronic Kidney Disease, Stage 4 (Severe), Chronic Kidney Disease, Stage 5
Hospices Civils de Lyon
Observational
70
Lyon
2025-01-01
Recruiting
AstraZeneca
Observational
126
Clermont-Ferrand, Gleizé, Grenoble, Lyon, Metz-Tessy, Saint-Etienne, Saint-Priest-en-Jarez, Thonon-les-Bains
2024-12-30
Recruiting
Hospices Civils de Lyon
Observational
100
Lyon
2024-12-30
Active, closed
Boehringer Ingelheim
Phase 2
90
Lyon, Rennes
2024-12-30
Recruiting
Hospices Civils de Lyon
Observational
125
Lyon
2024-12-19
Recruiting
Hospices Civils de Lyon
Observational
240
Clermont-Ferrand, Lille, Lyon, Nantes
2024-12-19
Recruiting
Nantes University Hospital
Not applicable
170
Bordeaux, Clermont-Ferrand, Grenoble, Lyon, Marseille, Nancy, Nantes, Paris
2024-12-18
Rows per page Showing 1–500 of 1395
1 2 3 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 30 October 2026. https://priyalifescience.com/clinical-trials-france/city/lyon

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,722 studies in total at the last sync on 29 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1,395 of those studies with a site in Lyon.

How many clinical trials are recruiting in Lyon?

789 of the 1,395 studies on this page are recruiting new participants as of the 29 Oct 2026, 03:20 UTC sync. A further 143 have not yet opened recruitment, 447 are active but closed to new participants, and 16 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Lyon), 1,395 studies
PhaseStudiesRecruitingShare
Phase 336718026.3%
Not applicable32721023.4%
Observational26216818.8%
Phase 220410014.6%
Phase 1/2101617.2%
Phase 185426.1%
Phase 2/325151.8%
Phase 424131.7%

Most active sponsors

Lead sponsors with the most studies (Lyon)
Lead sponsorStudiesRecruiting
Hospices Civils de Lyon188122
AstraZeneca6023
Centre Leon Berard5130
GCS Ramsay Santé pour l'Enseignement et la Recherche3519
Hoffmann-La Roche3512
Janssen Research & Development, LLC3312
Assistance Publique - Hôpitaux de Paris2721
Eli Lilly and Company279
Daiichi Sankyo2514
Novartis Pharmaceuticals237
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.